Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Hematology|August 6, 2016
A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphomaMili Arora, Sonia Gowda, Joseph Tuscano
Acta Haematologica|April 30, 2020
Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte LeukemiaChristina Poh, Mili Arora, Sudeep Ghuman, et al.
Frontiers in Oncology|November 6, 2024
Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphomaNaseem Esteghamat, Aaron Tsumura, Gabriel Marquez-Arreguin, et al.
The Oncologist|January 11, 2024
A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for LymphomaMichael Durando, Ajay K Gopal, Joseph Tuscano, et al.
Bone Marrow Transplantation|September 2, 2021
Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndromeBrian Pham, Rasmus Hoeg, Rajeev Krishnan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2020
A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic MalignanciesRasmus T Hoeg, Julian Davis, Brian A Jonas, et al.
Case Reports in Oncology|March 5, 2026
Utilization and Outcomes of High-Dose Methotrexate in CNS Lymphoma Patients on Hemodialysis: A Report of 2 CasesAneeqa Zafar, Hanna Yakubi, Benjamin Moskoff, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2016
Erythema Nodosum-like Septal Panniculitis Secondary to Lenalidomide Therapy in a Patient With Janus Kinase 2-Positive MyelofibrosisTatyana A Petukhova, Danielle M Tartar, Karen Mayo, et al.
Transplantation and Cellular Therapy|June 25, 2026
A Retrospective Study Evaluating the Efficacy of Fludarabine, Cytarabine, and Granulocyte Colony Stimulating Factor with/without Idarubicin Followed by Second Allogenic Stem Cell Transplant in the Treatment of Relapsed/Refractory AML/MDS Following First Allogenic Stem Cell TransplantJacqueline Hsieh-Wong, Brian Pham, Joseph Tuscano, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival EndpointAaron S Rosenberg, Thierry Facon, Kejal Parikh, et al.
Pageof 4